PIN1 and cancer: These results together demonstrate for the first time that miR-140-5p inhibits HCC by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways and suggest that such a new pathway could be explored for the diagnosis and treatment of HCC.